tirzepatide suomi Cipla launches Yurpeak® (tirzepatide), a one-weekly injectable therapy for managing obesity and type 2 diabetes mellitus (T2DM) — two of the country's most pressing health challenges. Cipla has the rights to distribute Welcome to Mounjaro® (tirzepatide injection)

Water, Niacinamide, Dipropylene Glycol, Glycerin, Propanediol, Butylene Glycol, Hydroxyethyl Urea, Diethoxyethyl Succinate, Hydroxyacetophenone, Caprylyl Glycol, Polyglyceryl-10 Laurate, Betaine, Citric Acid, Panthenol, Ethylhexylglycerin, Gluconolactone, Sodium Polyacrylate, Disodium EDTA, Ammonium Acryloyldimethyltaurate/VP Copolymer, Sodium Citrate, Maltodextrin, 1,2-Hexanediol, Gardenia Florida Fruit Extract, Dipotassium Glycyrrhizate, Sodium Hyaluronate, Ascorbic Acid, Pantolactone, Tocopherol, Capryloyl Salicylic Acid, Tranexamic Acid, Tremella Fuciformis (Mushroom) Extract, Caprylic/Capric Triglyceride, Ascorbyl Glucoside, Ubiquinone, Hydrogenated Lecithin, Magnesium Chloride, Alcohol, Glutathione, Polysorbate 80, Calcium Gluconate, Pyridoxine HCl, BHT, Yeast Extract, Cyanocobalamin

doi: 10.1007/s00216-020-02612-w

Huangs research focused on the design of lesion site-targeted MLT-like nanoparticles, named ConA-MelNPs, for the treatment of dry AMD

Heart Fail Rev 26:11411150

Read more about supplements for lowering homocysteine, including the evidence supporting key nutrients involved in methylation